Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (3)
Active Filters (3)
Clear All
1 - 12 of 191 Results
Sort by:
Best Match

IVIS Spectrum 2 and IVIS SpectrumCT 2 platform product note
The IVIS® Spectrum 2 and IVIS SpectrumCT 2 imaging systems expands upon the versatility of the, best-in-class predecessor platform enabling high sensitivity 2D and 3D bioluminescence and fluorescence imaging.

IVIS Spectrum 2 platform - illumination in focus
Discover the next generation in preclinical optical imaging, the IVIS Spectrum 2 and IVIS SpectruCT 2 systems.

DBS Sample Collection Instructions
This document provides guidance on the DBS collection and shipment.

89-Zirconium Radionuclide
Visualize and quantify uptake of monoclonal antibodies (mAb) with Zirconium-89 (89Zr) radionuclide

Deciphering the role of neutrophils in virus-induced respiratory disease
Preclinical imaging of neutrophilic response in viral infection with IVISense™ Neutrophil Elastase fluorescent probes.

Assessment of MYC-driven progression of small cell lung cancer
Researchers at Huntsman Cancer Center use GEMM and the Quantum microCT system for evaluating small cell lung cancer.

Drug discovery and development tailor made
Learn more about our Custom Discovery Reagent and Assay Services to further your research, backed by 30+ years of experience.

Radiochemical Custom Synthesis and Labeling
Radiochemical custom synthesis and labeling services from Revvity

wbs-discover-advanced-high-throughput-dna-extraction-techniques-for-population-studies-prime-ceph
Discover automated high-throughput DNA extraction for large-scale genomic studies and benefit from expert experiences. Watch this webinar now!

Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments
Find out about the effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in HCA screening experiments.

Pooled phenotypic CRISPR screening enables the identification of synergistic drug combinations for cancer therapy
This application note demonstrates how a pooled phenotypic CRISPR screening can be used to identify synergistic drug combinations for cancer therapy


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.